Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Urinary Bladder Neoplasms
×
tremelimumab
×
Clear all
Filters
3
NCT03682068
2026-02-03
NILE
AstraZeneca
Phase 3
Active not recruiting
1,246 enrolled
NCT04960709
2025-12-19
VOLGA
AstraZeneca
Phase 3
Active not recruiting
712 enrolled